AdvanCell is a biotechnology startup developing targeted alpha therapies for the treatment of prostate cancer.
The company is focused on advancing targeted therapeutic approaches and is expanding its U.S. manufacturing infrastructure to support development and scale.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$315M
Total Amount Raised$315M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$315M
Latest Funding Amount$315M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 17, 2026
Investment
$315.00M
―
Similar Companies
A snapshot of private companies similar to AdvanCell, helping you discover and navigate related company profiles.